You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

Article metrics

Article menu
Review
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: October 2021 to March 2026

AbstractFullPdf
Oct 2021764766229
Nov 202125625672
Dec 2021959631
Jan 2022989951
Feb 2022717137
Mar 2022929635
Apr 2022849030
May 2022919454
Jun 2022656634
Jul 2022777919
Aug 2022999934
Sep 2022818148
Oct 2022707035
Nov 2022454528
Dec 2022434311
Jan 2023333522
Feb 2023585811
Mar 2023384226
Apr 2023273123
May 2023222218
Jun 2023262612
Jul 2023292917
Aug 2023242410
Sep 2023323212
Oct 2023292916
Nov 2023555515
Dec 2023222213
Jan 202435368
Feb 2024293219
Mar 2024292935
Apr 2024434529
May 2024192015
Jun 2024393916
Jul 2024414121
Aug 2024262515
Sep 2024252516
Oct 2024323128
Nov 2024444521
Dec 2024505222
Jan 2025515114
Feb 2025414316
Mar 2025515124
Apr 2025797933
May 2025444622
Jun 2025424228
Mar 2026110
Total314731891325